메뉴 건너뛰기




Volumn , Issue 1, 2008, Pages

Statins for acute coronary syndrome

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

EID: 44949090497     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006870     Document Type: Review
Times cited : (27)

References (29)
  • 1
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • MEDLINE: 77, 4S 1994 Scandinavian Simvastatin Survival Study Group
    • 4S 1994 Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344(8934):1383-9. [MEDLINE: 77].
    • (1994) Lancet , vol.344 , Issue.8934 , pp. 1383-1389
  • 2
    • 34548384458 scopus 로고    scopus 로고
    • AHA 2007 American Heart Association, update. Available at, accessed August 2007] 2006
    • AHA 2007 American Heart Association. Heart disease and stroke statistics - 2007 update. Available at www.americanheart.org/statistics [accessed August 2007] 2006.
    • (2007) Heart disease and stroke statistics
  • 3
    • 0034672571 scopus 로고    scopus 로고
    • Arntz 2000 Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R, Fischer F, et al.Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). American Journal of Cardiology 2000;86(12):1293-8. [MEDLINE: 564].
    • Arntz 2000 Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R, Fischer F, et al.Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). American Journal of Cardiology 2000;86(12):1293-8. [MEDLINE: 564].
  • 4
    • 0035820313 scopus 로고    scopus 로고
    • Aronow 2001 Aronow HD, Topol EJ, Roe MT, Houghtaling PL, Wolski KE, Lincoff AM, et al.Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet 2001;357(9262):1063-8. [MEDLINE: 61].
    • Aronow 2001 Aronow HD, Topol EJ, Roe MT, Houghtaling PL, Wolski KE, Lincoff AM, et al.Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet 2001;357(9262):1063-8. [MEDLINE: 61].
  • 5
    • 33646173813 scopus 로고    scopus 로고
    • Briel 2006 Briel M, Schwartz GG, Thompson PL, DeLemos JA, Blazing MA, van Es GA, et al.Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes. A meta-analysis of randomized controlled trials. JAMA 2006;295:2046-56.
    • Briel 2006 Briel M, Schwartz GG, Thompson PL, DeLemos JA, Blazing MA, van Es GA, et al.Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes. A meta-analysis of randomized controlled trials. JAMA 2006;295:2046-56.
  • 6
    • 11144355354 scopus 로고    scopus 로고
    • Cannon 2004 Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al.Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New England Journal of Medicine 2004;350(15):1495-504. [MEDLINE: 570].
    • Cannon 2004 Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al.Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New England Journal of Medicine 2004;350(15):1495-504. [MEDLINE: 570].
  • 7
    • 44949129379 scopus 로고    scopus 로고
    • Deeks 1998 Deeks J, Bradburn M, Localio R, Berlin J. Much ado about nothing: statistical methods for meta-analysis with rare events. 6th Cochrane Colloquium, Baltimore, MD, USA. 1998.
    • Deeks 1998 Deeks J, Bradburn M, Localio R, Berlin J. Much ado about nothing: statistical methods for meta-analysis with rare events. 6th Cochrane Colloquium, Baltimore, MD, USA. 1998.
  • 8
    • 0022992740 scopus 로고
    • DerSimonian R, Laird N. Meta-analysis in clinical trials
    • DerSimonian
    • DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
    • (1986) Controlled Clinical Trials , vol.1986 , Issue.7 , pp. 177-188
  • 9
    • 84970861456 scopus 로고    scopus 로고
    • Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286- 91.
    • Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286- 91.
  • 10
    • 0033614802 scopus 로고    scopus 로고
    • Dupuis 1999 Dupuis J, Tardif JC, Cernacek P, Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 1999;99(25):3227-33. [MEDLINE: 40].
    • Dupuis 1999 Dupuis J, Tardif JC, Cernacek P, Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 1999;99(25):3227-33. [MEDLINE: 40].
  • 11
    • 23944497531 scopus 로고    scopus 로고
    • Fonarow 2005 Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al.Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. American Journal of Cardiology 2005;96(5):611-6. [MEDLINE: 680].
    • Fonarow 2005 Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al.Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. American Journal of Cardiology 2005;96(5):611-6. [MEDLINE: 680].
  • 12
    • 0037098199 scopus 로고    scopus 로고
    • Higgins 2002 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [MEDLINE: 533].
    • Higgins 2002 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [MEDLINE: 533].
  • 13
    • 0041876133 scopus 로고    scopus 로고
    • Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60. [MEDLINE: 411].
    • Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60. [MEDLINE: 411].
  • 14
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • MEDLINE: 11, HPS 2002 The Heart Protection Study Collaborative Group
    • HPS 2002 The Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7-22. [MEDLINE: 11].
    • (2002) Lancet , vol.360 , Issue.9326 , pp. 7-22
  • 15
    • 33749002873 scopus 로고    scopus 로고
    • Hulten 2006 Hulten E, Jackson JL, Douglas K, George S, Villines TC. The effect of early, intensive statin therapy on acute coronary syndrome. A meta-analysis of randomized controlled trials. Archives of Internal Medicine 2006;166:1814-21.
    • Hulten 2006 Hulten E, Jackson JL, Douglas K, George S, Villines TC. The effect of early, intensive statin therapy on acute coronary syndrome. A meta-analysis of randomized controlled trials. Archives of Internal Medicine 2006;166:1814-21.
  • 16
    • 85136445823 scopus 로고    scopus 로고
    • Juni 1999 Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials formeta-analysis. JAMA 1999;282(11):1054-60. [MEDLINE: 522].
    • Juni 1999 Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials formeta-analysis. JAMA 1999;282(11):1054-60. [MEDLINE: 522].
  • 17
    • 85136452605 scopus 로고    scopus 로고
    • Newby 2002 Newby LK, Kristinsson A, Bhapkar MV, Aylward PE, Dimas AP, Klein WW, et al.Early statin initiation and outcomes in patients with acute coronary syndromes. JAMA 2002;287(23):3087-95. [MEDLINE: 349].
    • Newby 2002 Newby LK, Kristinsson A, Bhapkar MV, Aylward PE, Dimas AP, Klein WW, et al.Early statin initiation and outcomes in patients with acute coronary syndromes. JAMA 2002;287(23):3087-95. [MEDLINE: 349].
  • 18
    • 0032169240 scopus 로고    scopus 로고
    • Ridker 1998 Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, et al.Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998;98(9):839-844. [MEDLINE: 34].
    • Ridker 1998 Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, et al.Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998;98(9):839-844. [MEDLINE: 34].
  • 19
    • 85136429477 scopus 로고    scopus 로고
    • Rosenson 1998 Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998;279(20):1643-50. [MEDLINE: 21].
    • Rosenson 1998 Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998;279(20):1643-50. [MEDLINE: 21].
  • 20
    • 0035804846 scopus 로고    scopus 로고
    • Schwartz 2001 Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285(13):1711-8. [MEDLINE: 6].
    • Schwartz 2001 Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285(13):1711-8. [MEDLINE: 6].
  • 21
    • 85136375313 scopus 로고    scopus 로고
    • Serruys 2002 Serruys PW, de Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al.Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;287(24):3215-22. [MEDLINE: 230].
    • Serruys 2002 Serruys PW, de Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al.Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;287(24):3215-22. [MEDLINE: 230].
  • 22
    • 0028883828 scopus 로고    scopus 로고
    • Shepherd 1995 Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New England Journal of Medicine 1995;333(20):1301-7. [MEDLINE: 78].
    • Shepherd 1995 Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New England Journal of Medicine 1995;333(20):1301-7. [MEDLINE: 78].
  • 23
    • 2542422856 scopus 로고    scopus 로고
    • Spencer 2004 Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, et al.Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Annals of Internal Medicine 2004;140(11):857-66. [MEDLINE: 562].
    • Spencer 2004 Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, et al.Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Annals of Internal Medicine 2004;140(11):857-66. [MEDLINE: 562].
  • 24
    • 0036790614 scopus 로고    scopus 로고
    • Sposito 2002 Sposito AC, Chapman MJ. Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit. Arteriosclerosis, Thrombosis & Vascular Biology 2002;22(10): 1524-34. [MEDLINE: 667].
    • Sposito 2002 Sposito AC, Chapman MJ. Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit. Arteriosclerosis, Thrombosis & Vascular Biology 2002;22(10): 1524-34. [MEDLINE: 667].
  • 25
    • 0037075262 scopus 로고    scopus 로고
    • Staffa 2002 Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. New England Journal of Medicine 2002;346(7):539-40. [MEDLINE: 172].
    • Staffa 2002 Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. New England Journal of Medicine 2002;346(7):539-40. [MEDLINE: 172].
  • 26
    • 85136403791 scopus 로고    scopus 로고
    • Stenestrand 2001 Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001;285(4):430-6. [MEDLINE: 60].
    • Stenestrand 2001 Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001;285(4):430-6. [MEDLINE: 60].
  • 27
    • 0035859525 scopus 로고    scopus 로고
    • Sterne 2001 Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001;323(7304):101-5. [MEDLINE: 632].
    • Sterne 2001 Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001;323(7304):101-5. [MEDLINE: 632].
  • 28
    • 17644421390 scopus 로고    scopus 로고
    • Studer 2005 Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC. Effect of different antilipidemic agents and diets on mortality: a systematic review. Archives of Internal Medicine 2005;165(7):725-30. [MEDLINE: 649].
    • Studer 2005 Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC. Effect of different antilipidemic agents and diets on mortality: a systematic review. Archives of Internal Medicine 2005;165(7):725-30. [MEDLINE: 649].
  • 29
    • 0032189666 scopus 로고    scopus 로고
    • Wood 1998 Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyorala K, et al.Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. European Heart Journal 1998;19(10):1434- 503. [MEDLINE: 357].
    • Wood 1998 Wood D, de Backer G, Faergeman O, Graham I, Mancia G, Pyorala K, et al.Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. European Heart Journal 1998;19(10):1434- 503. [MEDLINE: 357].


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.